MEVION S250 Product Usage: Proton Radiation Therapy
Recall Z-0409-2017, part of FDA recall event 75496. See Mevion Medical Systems's company page.
Mevion Medical Systems, Inc. started this Class II device recall on Oct 31, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Jun 29, 2017.
- Classification: Class II
- Started: Oct 31, 2016
- Status: Terminated
Completing Setup Without Program Move Complete Can Cause An Isocenter Error
- Product
- MEVION S250 Product Usage: Proton Radiation Therapy
- Quantity
- 6 units
- Lots and codes
- Serial NUmbers: S250-0001 through S250-0006
- Distribution
- US Nationwide in the states of FL, MO, NJ and OK
- Recalling firm
- Mevion Medical Systems, Inc., Littleton, MA, United States
- How the firm notified
- Letter
- FDA classified
- Nov 14, 2016
Newest first, one product per recall event; search them all
- Mevion S250 and S250i Proton Therapy Systems hand pendant (P/N 10263 or P/N 37808)Z-0827-2022 · Class II · Feb 1, 2022 · Ongoing
- MEVION S250i, MEVION S250; Proton Radiation Treatment System - Product Usage: intended to deliver proton radiation…Z-0485-2021 · Class II · Oct 19, 2020 · Terminated
- MEVION S250 Proton Radiation Treatment System; intended to deliver proton radiation treatment to patientsZ-2686-2020 · Class II · Jun 23, 2020 · Terminated
- MEVION S250i, MEVION S250; Proton Radiation Treatment SystemZ-2406-2020 · Class II · May 15, 2020 · Terminated
- MEVION S250iZ-0705-2019 · Class II · Oct 1, 2018 · Terminated
- MEVION S250/MEVION S250i Proton Beam Radiation therapy system Product Usage: Indicated for the delivery of…Z-2746-2018 · Class II · Jun 29, 2018 · Terminated
- MEVION S250-Proton Radiation Therapy Product Usage: Proton Radiation TherapyZ-1122-2017 · Class II · Dec 16, 2016 · Terminated
- MEVION S250 Product Usage: Proton Radiation Therapy SystemZ-0410-2017 · Class II · Oct 21, 2016 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports